Previous Close | 167.27 |
Open | 168.18 |
Bid | 166.89 x 100 |
Ask | 167.28 x 100 |
Day's Range | 165.85 - 169.34 |
52 Week Range | 125.82 - 335.91 |
Volume | |
Avg. Volume | 868,556 |
Market Cap | 11.713B |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | 56.89 |
EPS (TTM) | 2.94 |
Earnings Date | May 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 236.83 |
Strong global new customer starts fueled by the ongoing Omnipod 5 demand are expected to significantly benefit Insulet's (PODD) first-quarter performance.
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.